TWIK-2 channel deficiency leads to pulmonary hypertension through a rho-kinase-mediated process

Lavannya M. Pandit, Eric E. Lloyd, Julia O. Reynolds, William Lawrence, Corey Reynolds, Xander H T Wehrens, Robert M. Bryan

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

TWIK-2 (KCNK6) is a member of the 2-pore domain (K2P) family of potassium channels, which are highly expressed in the vascular system. We tested the hypothesis that TWIK-2 deficiency leads to pulmonary hypertension. TWIK-2 knockout mice and their wildtype littermates at 8 weeks of age had similar mean right ventricular systolic pressures (24±3 and 21±3 mm Hg, respectively.) Significantly, by 20 weeks of age, the mean right ventricular systolic pressures in TWIK-2 knockout mice increased to 35±3 mm Hg (P≤0.036), whereas mean right ventricular systolic pressures in wildtype littermates remained at 22±3 mm Hg. Elevated mean right ventricular systolic pressures in the TWIK-2 knockout mice was accompanied by pulmonary vascular remodeling as determined by a 25% increase in the cross-sectional area of the vessels occupied by the vessel wall. Additionally, secondary branches of the pulmonary artery from 20-week-old TWIK-2 knockout mice showed an enhanced contractile response to U46619 (10-6 moles/L), a thromboxane A2 mimetic, which was completely abolished with the Rho-kinase inhibitor, Y27632 (10-6 and 10-5 moles/L). Treatment of TWIK-2 knockout mice with the Rho-kinase inhibitor, fasudil, in the drinking water for 12 weeks, abolished the development of pulmonary hypertension and attenuated the vessel remodeling. We concluded that mice deficient in the TWIK-2 channel develop pulmonary hypertension between 8 and 20 weeks of age through a mechanism involving Rho-kinase. Our results suggest that downregulation of TWIK-2 in the pulmonary vasculature may be an underlying mechanism in the development of pulmonary hypertension.

Original languageEnglish (US)
Pages (from-to)1260-1265
Number of pages6
JournalHypertension
Volume64
Issue number6
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

rho-Associated Kinases
Pulmonary Hypertension
Knockout Mice
Ventricular Pressure
Blood Pressure
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Lung
Thromboxane A2
Potassium Channels
Drinking Water
Pulmonary Artery
Blood Vessels
Down-Regulation

Keywords

  • KCNK6
  • Potassium channel
  • Pulmonary hypertension
  • Rho-kinase
  • TWIK-2

ASJC Scopus subject areas

  • Internal Medicine
  • Medicine(all)

Cite this

Pandit, L. M., Lloyd, E. E., Reynolds, J. O., Lawrence, W., Reynolds, C., Wehrens, X. H. T., & Bryan, R. M. (2014). TWIK-2 channel deficiency leads to pulmonary hypertension through a rho-kinase-mediated process. Hypertension, 64(6), 1260-1265. https://doi.org/10.1161/HYPERTENSIONAHA.114.03406

TWIK-2 channel deficiency leads to pulmonary hypertension through a rho-kinase-mediated process. / Pandit, Lavannya M.; Lloyd, Eric E.; Reynolds, Julia O.; Lawrence, William; Reynolds, Corey; Wehrens, Xander H T; Bryan, Robert M.

In: Hypertension, Vol. 64, No. 6, 2014, p. 1260-1265.

Research output: Contribution to journalArticle

Pandit, LM, Lloyd, EE, Reynolds, JO, Lawrence, W, Reynolds, C, Wehrens, XHT & Bryan, RM 2014, 'TWIK-2 channel deficiency leads to pulmonary hypertension through a rho-kinase-mediated process', Hypertension, vol. 64, no. 6, pp. 1260-1265. https://doi.org/10.1161/HYPERTENSIONAHA.114.03406
Pandit, Lavannya M. ; Lloyd, Eric E. ; Reynolds, Julia O. ; Lawrence, William ; Reynolds, Corey ; Wehrens, Xander H T ; Bryan, Robert M. / TWIK-2 channel deficiency leads to pulmonary hypertension through a rho-kinase-mediated process. In: Hypertension. 2014 ; Vol. 64, No. 6. pp. 1260-1265.
@article{edb2789dd97e4465b3a5d5d65a8e4f5b,
title = "TWIK-2 channel deficiency leads to pulmonary hypertension through a rho-kinase-mediated process",
abstract = "TWIK-2 (KCNK6) is a member of the 2-pore domain (K2P) family of potassium channels, which are highly expressed in the vascular system. We tested the hypothesis that TWIK-2 deficiency leads to pulmonary hypertension. TWIK-2 knockout mice and their wildtype littermates at 8 weeks of age had similar mean right ventricular systolic pressures (24±3 and 21±3 mm Hg, respectively.) Significantly, by 20 weeks of age, the mean right ventricular systolic pressures in TWIK-2 knockout mice increased to 35±3 mm Hg (P≤0.036), whereas mean right ventricular systolic pressures in wildtype littermates remained at 22±3 mm Hg. Elevated mean right ventricular systolic pressures in the TWIK-2 knockout mice was accompanied by pulmonary vascular remodeling as determined by a 25{\%} increase in the cross-sectional area of the vessels occupied by the vessel wall. Additionally, secondary branches of the pulmonary artery from 20-week-old TWIK-2 knockout mice showed an enhanced contractile response to U46619 (10-6 moles/L), a thromboxane A2 mimetic, which was completely abolished with the Rho-kinase inhibitor, Y27632 (10-6 and 10-5 moles/L). Treatment of TWIK-2 knockout mice with the Rho-kinase inhibitor, fasudil, in the drinking water for 12 weeks, abolished the development of pulmonary hypertension and attenuated the vessel remodeling. We concluded that mice deficient in the TWIK-2 channel develop pulmonary hypertension between 8 and 20 weeks of age through a mechanism involving Rho-kinase. Our results suggest that downregulation of TWIK-2 in the pulmonary vasculature may be an underlying mechanism in the development of pulmonary hypertension.",
keywords = "KCNK6, Potassium channel, Pulmonary hypertension, Rho-kinase, TWIK-2",
author = "Pandit, {Lavannya M.} and Lloyd, {Eric E.} and Reynolds, {Julia O.} and William Lawrence and Corey Reynolds and Wehrens, {Xander H T} and Bryan, {Robert M.}",
year = "2014",
doi = "10.1161/HYPERTENSIONAHA.114.03406",
language = "English (US)",
volume = "64",
pages = "1260--1265",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - TWIK-2 channel deficiency leads to pulmonary hypertension through a rho-kinase-mediated process

AU - Pandit, Lavannya M.

AU - Lloyd, Eric E.

AU - Reynolds, Julia O.

AU - Lawrence, William

AU - Reynolds, Corey

AU - Wehrens, Xander H T

AU - Bryan, Robert M.

PY - 2014

Y1 - 2014

N2 - TWIK-2 (KCNK6) is a member of the 2-pore domain (K2P) family of potassium channels, which are highly expressed in the vascular system. We tested the hypothesis that TWIK-2 deficiency leads to pulmonary hypertension. TWIK-2 knockout mice and their wildtype littermates at 8 weeks of age had similar mean right ventricular systolic pressures (24±3 and 21±3 mm Hg, respectively.) Significantly, by 20 weeks of age, the mean right ventricular systolic pressures in TWIK-2 knockout mice increased to 35±3 mm Hg (P≤0.036), whereas mean right ventricular systolic pressures in wildtype littermates remained at 22±3 mm Hg. Elevated mean right ventricular systolic pressures in the TWIK-2 knockout mice was accompanied by pulmonary vascular remodeling as determined by a 25% increase in the cross-sectional area of the vessels occupied by the vessel wall. Additionally, secondary branches of the pulmonary artery from 20-week-old TWIK-2 knockout mice showed an enhanced contractile response to U46619 (10-6 moles/L), a thromboxane A2 mimetic, which was completely abolished with the Rho-kinase inhibitor, Y27632 (10-6 and 10-5 moles/L). Treatment of TWIK-2 knockout mice with the Rho-kinase inhibitor, fasudil, in the drinking water for 12 weeks, abolished the development of pulmonary hypertension and attenuated the vessel remodeling. We concluded that mice deficient in the TWIK-2 channel develop pulmonary hypertension between 8 and 20 weeks of age through a mechanism involving Rho-kinase. Our results suggest that downregulation of TWIK-2 in the pulmonary vasculature may be an underlying mechanism in the development of pulmonary hypertension.

AB - TWIK-2 (KCNK6) is a member of the 2-pore domain (K2P) family of potassium channels, which are highly expressed in the vascular system. We tested the hypothesis that TWIK-2 deficiency leads to pulmonary hypertension. TWIK-2 knockout mice and their wildtype littermates at 8 weeks of age had similar mean right ventricular systolic pressures (24±3 and 21±3 mm Hg, respectively.) Significantly, by 20 weeks of age, the mean right ventricular systolic pressures in TWIK-2 knockout mice increased to 35±3 mm Hg (P≤0.036), whereas mean right ventricular systolic pressures in wildtype littermates remained at 22±3 mm Hg. Elevated mean right ventricular systolic pressures in the TWIK-2 knockout mice was accompanied by pulmonary vascular remodeling as determined by a 25% increase in the cross-sectional area of the vessels occupied by the vessel wall. Additionally, secondary branches of the pulmonary artery from 20-week-old TWIK-2 knockout mice showed an enhanced contractile response to U46619 (10-6 moles/L), a thromboxane A2 mimetic, which was completely abolished with the Rho-kinase inhibitor, Y27632 (10-6 and 10-5 moles/L). Treatment of TWIK-2 knockout mice with the Rho-kinase inhibitor, fasudil, in the drinking water for 12 weeks, abolished the development of pulmonary hypertension and attenuated the vessel remodeling. We concluded that mice deficient in the TWIK-2 channel develop pulmonary hypertension between 8 and 20 weeks of age through a mechanism involving Rho-kinase. Our results suggest that downregulation of TWIK-2 in the pulmonary vasculature may be an underlying mechanism in the development of pulmonary hypertension.

KW - KCNK6

KW - Potassium channel

KW - Pulmonary hypertension

KW - Rho-kinase

KW - TWIK-2

UR - http://www.scopus.com/inward/record.url?scp=84922480956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922480956&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.114.03406

DO - 10.1161/HYPERTENSIONAHA.114.03406

M3 - Article

C2 - 25245387

AN - SCOPUS:84922480956

VL - 64

SP - 1260

EP - 1265

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 6

ER -